全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

The Impact of Risk Factors Reduction Scenarios on Hospital Admissions, Disability-Adjusted Life Years and the Hospitalisation Cost of Cardiovascular Disease in Thailand

DOI: 10.4236/oalib.1106160, PP. 1-21

Subject Areas: Public Health, Cardiology

Keywords: Cardiovascular Disease (CVD), Disability-Adjusted Life Years (DALYs), Cost of Admission, Risk Factors

Full-Text   Cite this paper   Add to My Lib

Abstract

Cardiovascular disease (CVD) is considered to be one of the leading health issues in Thailand. CVD not only contributes to an increase in the number of hospital admissions year by year but also impacts on the rising health care expenditure for the treatment and long-term care of CVD patients. Therefore, this study is aimed at examining the impacts of risk reduction strategies on the number of CVD hospital admissions, Disability-Adjusted Life Years (DALYs) and the costs of hospitalisation. To estimate such impacts a CVD cost-offset model was applied using a Microsoft Excel spreadsheet. The number of the mid-year population was classified by age, gender and the CVD risk factor profiles from the recent Thai National Health Examination Survey (NHES) IV. This survey was chosen as the baseline population. The CVD risk factor profiles included age, gender, systolic blood pressure, total cholesterol, and smoking status. The Asia-Pacific Collaborative Cohort Study (APCCS) equation was applied to predict the probability of developing CVD over the next eight-year period. Estimates on the following were obtained from the model: 1) the CVD events both fatal and non-fatal; 2) the difference between the projected number of deaths and the actual number of deaths in that population; 3) the number of patients who are expected to live with CVD; 4) the DALYs from the estimated number of fatal and non-fatal events; 5) the cost of hospital admissions. Four CVD risk strategy scenarios were investigated as follows: 1) the do-nothing scenario; 2) the optimistic scenario; 3) achieve the UN millennium development goal; and 4) the worst-case scenario. The findings showed that over the next eight years, there are likely to be 3,297,428 recorded cases of CVD; 5,870,049 cases of DALYs; and, approximately ?57,000 million, ($1.9 billion), is projected as the total cost of hospital admissions. However, if the current health policy can reduce the levels of risk factors as defined in the optimistic scenario or such policy meets the specifications of the UN millennium development goal, there would be a significant reduction in the number of hospital admissions. These are estimated to be a reduction of 522,179 male and 515,416 female cases. With these results, it is expected that health care costs would save approximately ?9000 million, ($298.3 million), for CVD and 900,000 million DALYs over the next eight years. However, if there is an upward trend in the risk factors as predicted in the worst-case scenario, then there will be an increase of 428,220 CVD cases; consequently, DALYs cases may rise by 766,029 while the hospit- alisation costs may increase by approximately ?7000 million, ($232.1 million). Based on our findings, reducing the levels of CVD risk factors in the population will drastically reduce: 1) the number of CVD cases; 2) DALYs cases; and 3) health care costs. Therefore it is recommended that the health policy should enhance the primary prevention programs which would be targeted at reducing the CVD risk factors in the population.

Cite this paper

Inthavong, R. , Khatab, K. , Whitfield, M. , Collins, K. , Ismail, M. and Raheem, M. (2020). The Impact of Risk Factors Reduction Scenarios on Hospital Admissions, Disability-Adjusted Life Years and the Hospitalisation Cost of Cardiovascular Disease in Thailand. Open Access Library Journal, 7, e6160. doi: http://dx.doi.org/10.4236/oalib.1106160.

References

[1]  Bureau of Non-Communicable Disease, Department of Disease Control, Ministry of Public Health (2010) Annual Report 2009. Office of Veterans Affairs Printing Organization under the Royal Patronage, Thailand.
[2]  Asia Pacific Cohort Studies Collaboration (2007) Cholesterol, Diabetes and Major Cardiovascular Diseases in the Asia-Pacific Region. Diabetologia, 50, 2289-2297. https://doi.org/10.1007/s00125-007-0801-2
[3]  Aekplakorn, W., et al. (2010) The CVD Risk Factors Profile from the NHESIV in 2009. National Health Examination Survey IV Report 2008-2009. The Graphic System Co., Ltd., Thailand.
[4]  International Health Policy Program (2012) Burden of Diseases and Injury in Thailand 2009. The Graphic System, Thailand.
[5]  Yusuf, H.R., Giles, W.H., Croft, J.B., Anda, R.F. and Casper, M.L. (1998) Impact of Multiple Risk Factor Profiles on Determining Cardiovascular Disease Risk. Preventive Medicine, 27, 1-9. https://doi.org/10.1006/pmed.1997.0268
[6]  Lloyd-Jones, D.M., Larson, M.G., Beiser, A. and Levy, D. (1999) The Lifetime Risk of Developing Coronary Heart Disease. The Lancet, 353, 89-92. https://doi.org/10.1016/S0140-6736(98)10279-9
[7]  McGowan, C., Yusuf, S., Islam, S., Jung, H., Rangarajan, S., Avezum, A., Dans, A.L., et al. (2010) Estimating Modifiable Coronary Heart Disease Risk in Multiple Regions of the World: The INTERHEART Modifiable Risk Score. European Heart Journal, 32, 581-589. https://doi.org/10.1093/eurheartj/ehq448
[8]  Yusuf, S., Hawken, S., ?unpuu, S., Dans, T., Avezum, A., Lanas, F. and Lisheng, L. (2004) Effect of Potentially Modifiable Risk Factors Associated with Myocardial Infarction in 52 Countries (the INTERHEART Study): A Case-Control Study. The Lancet, 364, 937-952. https://doi.org/10.1016/S0140-6736(04)17018-9
[9]  Bureau of Non-Communicable Disease, Department of Disease Control, Ministry of Public Health (2012) Guideline for Assessment of Cardiovascular Diseases Risk. WVO Office of Printing, War Veterans Organization of Thailand under the Royal Patronage of His Majesty the King, Bangkok, Thailand.
[10]  Suet-Lam, M. (1999) Projecting Coronary Heart Disease Incidence and Cost in Australia: Results from the Incidence Module of the Cardiovascular Disease Policy Model. Australian and New Zealand Journal of Public Health, 23, 11-19. https://doi.org/10.1111/j.1467-842X.1999.tb01199.x
[11]  Heidenreich, P.A., et al. (2011) Forecasting the Future of Cardiovascular Disease in the United States. Circulation, 123, 933-944. https://doi.org/10.1161/CIR.0b013e31820a55f5
[12]  Kang, H.Y., Lim, S.J., Suh, H.S. and Liew, D. (2011) Estimating the Lifetime Economic Burden of Stroke According to the Age of Onset in South Korea: A Cost of Illness Study. BMC Public Health, 11, Article No. 646. https://doi.org/10.1186/1471-2458-11-646
[13]  Grover, S.A., Paquet, S., Levinton, C., Coupal, L. and Zowall, H. (1998) Estimating the Benefits of Modifying Risk Factors of Cardiovascular Disease: A Comparison of Primary vs Secondary Prevention. Archives of Internal Medicine, 158, 655-662. https://doi.org/10.1001/archinte.158.6.655
[14]  Capewell, S., Morrison, C.E. and Mcmurray, J.J. (1999) The Contribution of Modern Cardiovascular Treatment and Risk Factor Changes to the Decline in Coronary Heart Disease Mortality in Scotland between 1975 and 1994. Heart, 81, 380-386. https://doi.org/10.1136/hrt.81.4.380
[15]  Goldman, l., et al. (2001) The Effect of Risk Factor Reductions between 1981 and 1990 on Coronary Heart Disease Incidence, Prevalence, Mortality and Cost. Journal of the American College of Cardiology, 38, 1012-1017. https://doi.org/10.1016/S0735-1097(01)01512-1
[16]  Whitfield, M.D., et al. (2006) Predicting the Impact of Population-Level Risk Reduction in Cardiovascular Disease and Stroke on Acute Hospital Admission Rates over a 5-Year Period—A Pilot Study. Public Health, 120, 1140-1148. https://doi.org/10.1016/j.puhe.2006.10.012
[17]  Moran, A., Gu, D., Zhao, D., Coxson, P., Wang, Y.C., Chen, C.S., Liu, J., Cheng, J., Bibbins-Domingo, K., Shen, Y.M. and He, J. (2010) Future Cardiovascular Disease in China: Markov Model and Risk Factor Scenario Projections from the Coronary Heart Disease Policy Model-China. Circulation. Cardiovascular Quality and Outcomes, 3, 243-252. https://doi.org/10.1161/CIRCOUTCOMES.109.910711
[18]  Lim, S.S., Gaziano, T.A., Gakidou, E., Reddy, K.S., Farzadfar, F., Lozano, R. and Rodgers, A. (2007) Prevention of Cardiovascular Disease in High-Risk Individuals in Low-Income and Middle-Income Countries: Health Effects and Costs. The Lancet, 370, 2054-2062. https://doi.org/10.1016/S0140-6736(07)61699-7
[19]  Conly, J., Clement, F., Tonelli, M., Hemmelgarn, B., Klarenbach, S., Lloyd, A., Manns, B., et al. (2011) Cost-Effectiveness of the Use of Low- and High-Potency Statins in People at Low Cardiovascular Risk. Canadian Medical Association Journal, 183, E1180-E1188. https://doi.org/10.1503/cmaj.101281
[20]  Cobiac, L.J., Magnus, A., Lim, S., Barendregt, J.J., Carter, R. and Vos, T. (2012) Which Interventions Offer the Best Value for Money in Primary Prevention of Cardiovascular Disease? PLoS ONE, 7, e41842. https://doi.org/10.1371/journal.pone.0041842
[21]  Mannan, H.R., Knuiman, M. and Hobbs, M. (2008) Adopting a Markov Monte Carlo Simulation Model for Forecasting the Number of Coronary Artery Revascularisation Procedures in an Era of Rapidly Changing Technology and Policy. BMC Medical Informatics and Decision Making, 8, 27. https://doi.org/10.1186/1472-6947-8-27
[22]  Dodhia, H., Phillips, K., Zannou, M.I., Airoldi, M. and Bevan, G. (2012) Modelling the Impact on Avoidable Cardiovascular Disease Burden and Costs of Interventions to Lower SBP in the England Population. Journal of Hypertension, 30, 217-226. https://doi.org/10.1097/HJH.0b013e32834d86ee
[23]  Aekplakorn, W. (2010) Thai National Health Examination Survey, NHES IV. The Graphic System Co., Ltd., Nonthaburi.
[24]  Barzi, F., Patel, A., Gu, D., Sritara, P., Lam, T.H., Rodgers, A. and Woodward, M. (2007) Cardiovascular Risk Prediction Tools for Populations in Asia. Journal of Epidemiology and Community Health, 61, 115-121. https://doi.org/10.1136/jech.2005.044842
[25]  Mathers, C.D., Vos, T., Lopez, A.D., Salomon, J. and Ezzati, M. (2001) National Burden of Disease Studies: A Practical Guide. World Health Organization, Geneva.
[26]  Drummond, M.F., Sculpher, M.J., Torrance, G.W., O’Brien, B.J. and Stoddart, G.L. (2005) Methods for the Economic Evaluation Of Health Care Programmes. 3rd Edition, Oxford University Press, Oxford.
[27]  Murray, C.J.L. and Lopez, A.D. (1996) Global Burden of Disease and Injury Series. Volume 1. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Disease, Injuries and Risk Factors in 1990 and Projected to 2020. Harvard University Press, Cambridge.
[28]  Bundhamcharoen, K., Odton, P., Phulkerd, S. and Tangcharoensathien, V. (2011) The Burden of Disease in Thailand: Changes in Health Gap between 1999 and 2004. BMC Public Health, 11, 53. https://doi.org/10.1186/1471-2458-11-53
[29]  World Health Organization (2016) DisMod II. https://www.epigear.com/index_files/dismod_ii.html
[30]  Barendregt, J.J. (2010) EpiGear International. https://www.epigear.com/
[31]  Inthawong, R. (2015) Assessing the Impact of Reducing Risk Factors for Cardiovascular Disease in Thailand. Doctoral Dissertation, Sheffield Hallam University, United Kingdom.
[32]  Allen, L., Cobiac, L. and Townsend, N. (2017) Quantifying the Global Distribution of Premature Mortality from Non-Communicable Diseases. Journal of Public Health, 39, 698-703. https://doi.org/10.1093/pubmed/fdx008
[33]  World Health Organization (2000) Standard Life Table West Level 26 [Computer Program]. http://www.who.int/healthinfo/bodreferencestandardlifetable.xls
[34]  Kontis, V., Mathers, C.D., Rehm, J., Stevens, G.A., Shield, K.D., Bonita, R. and Ezzati, M. (2014) Contribution of Six Risk Factors to Achieving the 25 × 25 Non- Communicable Disease Mortality Reduction Target: A Modelling Study. The Lancet, 384, 427-437. https://doi.org/10.1016/S0140-6736(14)60616-4
[35]  World Health Organization (2011) Global Status Report on Non-Communicable Diseases 2010. WHO Press, Geneva, Switzerland. http://whqlibdoc.who.int/publications/2011/9789240686458_eng.pdf
[36]  Sangthong, R., Chongsuvivatwong, V., Geater, A.F. and Jitpiboon, W. (2011) Decreasing Trends of Smoking and Smoking Cessation in Successive Thai Birth Cohorts: Age-Period-Cohort Analysis from 1991-2007 National Surveys. Asian Pacific Journal of Cancer Prevention, 12, 3081-3085.
[37]  Knodel, J. and Chayovan, N. (2008) Population Ageing and the Well-Being of Older Persons in Thailand: Past Trends, Current Situation and Future Challenges. UNFPA Thailand and Asia and the Pacific Regional Office.
[38]  Inthawong, R., Khatab, K., Whitfield, M., et al. (2019) Application of Cardiovascular Disease (CVD) Risk Assessment Equations to the Thai Population. Biostatistics & Epidemiologya, 2, 18. https://doi.org/10.30881/beij.00013

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413